Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02016885 · ClinicalTrials.gov registry record · Phase 2
A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis
A Phase 2 study, sponsored by Journey Medical Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 198
- Enrollment target
NCT02016885 is a Phase 2 study that has completed, run by Journey Medical Corporation. The registered enrollment target is 198 participants.
The verdict
NCT02016885, a Phase 2 study, has completed, sponsored by Journey Medical Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 198 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of glycopyrrolate compared to vehicle for the treatment of axillary hyperhidrosis.
Interventions
- OTHER Vehicle
- DRUG glycopyrrolate, 1.0%
- DRUG glycopyrrolate, 2.0%
- DRUG glycopyrrolate, 3.0%
- DRUG glycopyrrolate, 4.0%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02016885
The ClinicalTrials.gov registry entry for NCT02016885 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Journey Medical Corporation, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Vehicle is the first listed.
NCT02016885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02016885 about?
NCT02016885 is a clinical study titled "A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis". The purpose of this study is to evaluate the safety and efficacy of glycopyrrolate compared to vehicle for the treatment of axillary hyperhidrosis.
What is the current status of trial NCT02016885?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 198 participants. The study started on 2013-11. Estimated completion is 2014-09.
What interventions are being tested in trial NCT02016885?
The interventions under investigation include: Vehicle (OTHER), glycopyrrolate, 1.0% (DRUG), glycopyrrolate, 2.0% (DRUG), glycopyrrolate, 3.0% (DRUG), glycopyrrolate, 4.0% (DRUG).
Who is sponsoring clinical trial NCT02016885?
This trial is sponsored by Journey Medical Corporation, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.